CLASS II ONGOING Device recall · Reported 10 Apr 2024 · FDA Enforcement Report

Architect Anti-HCV Reagent Kit, List Numbers: a) 1L79-25, b) 1L79 recalled

Abbott is recalling Architect Anti-HCV Reagent Kit, List Numbers: a) 1L79-25, b) 1L79-35, distributed nationwide in the US. The recall was initiated on 4 Mar 2024 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesa) 1L79-25, 00380740001414, Lot Numbers: 52011BE00, 54140BE00, 56375BE00, 58163BE00, 59194BE00; b) 1L79-35, 00380740001421, Lot Numbers: 52015BE00, 54144BE00, 56379BE00, 58167BE00, 59198BE00
Quantity recalled7219 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1479-2024
FDA event ID
94205
Recalling firm
Abbott, Wiesbaden
Classification
Class II
Status
Ongoing
Recall initiated
4 Mar 2024
FDA classified
4 Apr 2024
Reported
10 Apr 2024
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Lead & Heavy Metals

Timeline

4 Mar 2024Recall initiated by company
4 Apr 2024Classified by FDA+31 days
10 Apr 2024Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Customer complaints were received regarding falsely elevated results for some patient samples. Internal studies with customer return samples confirmed potential interactions that may lead to falsely elevated results when processed as below on the same instrument: " ARCHITECT Syphilis TP (LN 8D06) and/or ARCHITECT AdviseDx SARS-CoV-2-IgG II (LN 6S60) precedes ARCHITECT Anti-HCV testing (LN 1L79). " Alinity i Syphilis TP (LN 07P60) precedes Alinity i Anti-HCV testing (LN 08P05).

Lead and other heavy metals accumulate in the body. Children are most at risk; even low levels can affect development.

Product as listed by the FDA

ARCHITECT Anti-HCV Reagent Kit, List Numbers: a) 1L79-25, b) 1L79-35

Where it was distributed

US Nationwide distribution.

Nationwide

Questions about this recall

Is Architect Anti-HCV Reagent Kit, List Numbers: a) 1L79-25, b) 1L79-35 recalled?

Yes. Abbott recalled Architect Anti-HCV Reagent Kit, List Numbers: a) 1L79-25, b) 1L79-35 on 4 Mar 2024. The recall is Class II and its status is Ongoing. Recall number Z-1479-2024.

Why was it recalled?

Customer complaints were received regarding falsely elevated results for some patient samples. Internal studies with customer return samples confirmed potential interactions that may lead to falsely elevated results when processed as below on the same instrument: " ARCHITECT Syphilis TP (LN 8D06) and/or ARCHITECT AdviseDx SARS-CoV-2-IgG II (LN 6S60) precedes ARCHITECT Anti-HCV testing (LN 1L79). " Alinity i Syphilis TP (LN 07P60) precedes Alinity i Anti-HCV testing (LN 08P05).

Which lots are affected?

a) 1L79-25, 00380740001414, Lot Numbers: 52011BE00, 54140BE00, 56375BE00, 58163BE00, 59194BE00; b) 1L79-35, 00380740001421, Lot Numbers: 52015BE00, 54144BE00, 56379BE00, 58167BE00, 59198BE00

Where was it sold?

US Nationwide distribution.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Abbott

All 20

Other Test Kits & Diagnostics recalls

All 2,656